• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Endogenex

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

  • ReCET
  • Patients
  • Clinical Providers
  • About Us
    • News
    • Contact
  • Clinical Studies

CBS Minnesota report: Mayo Clinic participates in study to evaluate novel Type 2 Diabetes treatment

Thirty-seven million Americans, or 1 in 10, have diabetes. In a recent interview by CBS Minnesota, Dr. Andrew Storm of Mayo Clinic, spoke about the new diabetes treatment that may help people with Type 2 Diabetes control their blood sugar levels.

In the on-air interview. Dr. Storm addresses how people come to develop Type 2 Diabetes which typically develops because of lifestyle—over-indulgences, diet and inactivity. These factors lead to our bodies becoming overwhelmed with too much sugar in our systems and in many instances, means we need to enlist the help of medications such as insulin to circumvent the sugar intake.

Dr. Storm spoke about the investigational ReCET Procedure, developed as an option for patients with Type 2 Diabetes and being evaluated in the REGENT-1 clinical study.

Watch the CBS broadcast in full to learn about ReCET as an option to treat Type 2 Diabetes.

Next Post:Clinical study participant with Type 2 Diabetes shares his story

* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Endogenex, Inc.
151 Cheshire Ln N #400
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

  • Facebook
  • Twitter
  • LinkedIn
  • Vimeo

References

Terms of Use

Privacy Policy

Cookie Policy

Join our mailing list


EndogenexTM and ReCETTM are registered trademarks of Endogenex, Inc. in the United States and other countries.

Copyright © 2023 Endogenex, Inc. All rights reserved.